The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Exosome-Based Cell-Cell Communication in the Tumor Microenvironment
Open accessAbstract
Tumors are not isolated entities, but complex systemic networks involving cell-cell communication between transformed and non-transformed cells. The milieu created by tumor-associated cells may either support or halt tumor progression. In addition to cell-cell contact, cells communicate through secreted factors via a highly complex system involving characteristics such as ligand concentration, receptor expression and integration of diverse signaling pathways. Of these, extracellular vesicles, such as exosomes, are emerging as novel cell-cell communication mediators in physiological and pathological scenarios. Exosomes, membrane vesicles of endocytic origin released by all cells (both healthy and diseased), ranging in size from 30 to 150 nm, transport all the main biomolecules, including lipids, proteins, DNAs, messenger RNAs and microRNA, and perform intercellular transfer of components, locally and systemically. By acting not only in tumor cells, but also in tumor-associated cells such as fibroblasts, endothelium, leukocytes and progenitor cells, tumor- and non-tumor cells-derived exosomes have emerged as new players in tumor growth and invasion, tumor-associated angiogenesis, tissue inflammation and immunologic remodeling. In addition, due to their property of carrying molecules from their cell of origin to the peripheral circulation, exosomes have been increasingly studied as sources of tumor biomarkers in liquid biopsies. Here we review the current literature on the participation of exosomes in the communication between tumor and tumor-associated cells, highlighting the role of this process in the setup of tumor microenvironments that modulate tumor initiation and metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–217 of 217
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death
Czystowska, M., Han, J., Szczepański, M. J., Szajnik, M. E., Quadrini, K. J., Brandwein, H. J., Hadden, J. W., Signorelli, K. L., & Whiteside, T. L. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2008.197 · Cited by 76
Dendritic cell-derived exosomes for cancer immunotherapy: hope and challenges
Tian, H., & Li, W. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.02.23 · Cited by 76
Soekmadji, C., Riches, J. D., Russell, P. J., Ruelcke, J. E., McPherson, S. J., Wang, C., Hovens, C. M., Corcoran, N. M., Hill, M. M. C., & Nelson, C. C. (2016) · Oncotarget · doi:10.18632/oncotarget.11111 · Cited by 75
Perone, M. J., Larregina, A. T., Shufesky, W. J., Papworth, G. D., Sullivan, M. L. G., Zahorchak, A. F., Stolz, D. B., Baum, L. G., Watkins, S. C., Thomson, A. W., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7207 · Cited by 61
Abdouh, M., Hamam, D., Gao, Z., Arena, V., Arena, M., & Arena, G. O. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0587-0 · Cited by 61
Silva, T. A., Smuczek, B., Valadão, I. C., Dzik, L. M., Iglesia, R. P., Cruz, M. C., Zelanis, A., de Siqueira, A. S., Serrano, S. M. T., Goldberg, G. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10307 · Cited by 58
Saito, H., Takaya, S., Osaki, T., & Ikeguchi, M. (2012) · Gastric Cancer · doi:10.1007/s10120-012-0210-1 · Cited by 53
BCR‐bound antigen is targeted to exosomes in human follicular lymphoma B‐cells1
Rialland, P., Lankar, D., Raposo, G., Bonnerot, C., & Hubert, P. (2006) · Biology of the Cell · doi:10.1042/bc20060027 · Cited by 51
The Platelet‐like Activity of Serum.
O’Brien, J. R. (1955) · British Journal of Haematology · doi:10.1111/j.1365-2141.1955.tb05503.x · Cited by 49
Esophageal cancer‐derived microvesicles induce regulatory B cells
Li, Y., An, J., Huang, S., He, J., & Zhang, J. (2015) · Cell Biochemistry and Function · doi:10.1002/cbf.3115 · Cited by 48
Reiners, K. S., Daßler, J., Coch, C., & von Strandmann, E. P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00091 · Cited by 45
Hamam, D., Abdouh, M., Gao, Z., Arena, V., Arena, M., & Arena, G. O. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0360-9 · Cited by 43
MicroRNAs contribution in tumor microenvironment of esophageal cancer
Nouraee, N., Khazaei, S., Vasei, M., Razavipour, S. F., Sadeghizadeh, M., & Mowla, S. J. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160575 · Cited by 38
Small But Mighty: Microparticles as Mediators of Tumor Progression
Voloshin, T., Fremder, E., & Shaked, Y. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0144-8 · Cited by 34
Bergström, S. H., Hägglöf, C., Thysell, E., Bergh, A. R. J., Wikström, P., & Lundholm, M. (2016) · Scientific Reports · doi:10.1038/srep31805 · Cited by 24
Is the exosome a potential target for cancer immunotherapy?
Yoshimura, A., Sawada, K., & Kimura, T. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.47 · Cited by 16
Pre-Metastatic Niche Formation Has Taken Its TOLL
Kenific, C. M., Nogués, L., & Lyden, D. C. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.012 · Cited by 12
Cited by
An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Saliminejad, K., Khorram Khorshid, H. R., Soleymani Fard, S., & Ghaffari, S. H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27486 · Cited by 1,872
Gurunathan, S., Kang, M.-H., Jeyaraj, M., Qasim, M., & Kim, J.-H. (2019) · Cells · doi:10.3390/cells8040307 · Cited by 1,122
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · doi:10.20944/preprints201810.0507.v1 · Cited by 605
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040218 · Cited by 603
Li, X., Corbett, A. L., Taatizadeh, E., Tasnim, N., Little, J. P., Garnis, C., Daugaard, M., Guns, E., Hoorfar, M., & Li, I. T. S. (2019) · APL Bioengineering · doi:10.1063/1.5087122 · Cited by 564
Metadata
- Authors
- Maia, J., Caja, S., Strano Moraes, M. C., Couto, N., & Costa-Silva, B.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2018-02-20
- Volume
- 6
- Pages
- 18-18
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W2798033749
- Cited by
- 666
- References
- 217
- FWCI
- 24.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.